The SA Journal Diabetes & Vascular Disease Vol 14 No 1 (July 2017)

19 / 44

VOLUME 14 NUMBER 1 • JULY 2017 17
SA JOURNAL OF DIABETES & VASCULAR DISEASE REVIEW
15. Cameron FJ, de Beaufort C, Aanstoot HJ, et al.; Hvidoere International Study
Group. Lessons from the Hvidoere International Study Group on childhood
diabetes: be dogmatic about outcome and flexible in approach. Pediatric
Diabetes 2013; 14: 473–480.
16. Bennett ST, Todd JA. Human type 1A diabetes and the insulin gene: principles of
mapping polygenes. A Rev Genet 1996; 30: 343–370.
17. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG. Insulin
expression in human thymus is modulated by INS VNTR alleles at the IDDM2
locus. Nat Genet 1997; 15(3): 289–292.
18. Beckerle CM, Lavin MA. Association of self-efficacy and self-care with glycemic
control in diabetes. Diabetes Spect 2013: 26(3): 172–178.
19. Hapunda G. Psychosocial Functioning in Individuals with Diabetes Mellitus in
Zambia. Ridderkerk: The Netherlands, 2015.
20. Devendra D, Liu E, Eisenbarth SG. Type I diabetes: Recent developments. Biomed
J 2004; 328(7442): 750–754.
21. Redondo MJ, Rewers M, Yu L, Garg S, Pilcher CC, Elliott RB. Genetic determination
of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin
siblings of patients with type 1A diabetes: prospective twin study. Br Med J 1999;
318: 698–702.
22. Wiegard S, Raile K, Reinehr T, Hofer S, Năke A, Rabi W, Holl RW; DPV-Wiss Study
Group. Daily insulin requirement of children and adolescents with type 1 diabetes:
effects of age, gender, body mass index and mode of therapy. Eur J Endocrinol
2008; 158(4): 543–549.
23. Khadikar VV, Parthasarathy LS, Mallade BB, Khadikar AV, Chiplonkar SA, Borade
AB. Growth status of children and adolescents with type 1 diabetes mellitus. Ind
J Endocrinol Metab 2013; 17(16): 1057–1060.
24. Kalk WJ, Huddle KRL, Raal FJ. The age of onset of insulin-dependent diabetes
mellitus in Africans in South Africa. Postgrad Med J 1993; 69(813): 552–556.
25. Lester FT. The clinical pattern of diabetes mellitus in Ethiopia. Diabetes Care 1984;
7: 6–11.
26. Afoke AO, Ejeh NM, Nwonu EN, Okafor CO, Udeh NJ, Ludvigsson J. Prevalence
and clinical picture of IDDM in Nigerian Ibo school children. Diabetes Care 1992;
15(10): 1310–1312.
27. Swai ABM, Lutale J, McLarty DG. Prospective study of incidence of juvenile
diabetes mellitus over 10 years in Dar es Salaam, Tanzania. Br Med J 1993;
306(6892): 1570–1572.
28. Benoit SS, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among
patients with type 2 diabetes: A longitudinal study. BMC Public Health 2005;
5(36).
29. Naughton MJ, Yi-Frazier JP, Morgan TM, Seid M, Lawrence JM, Klingensmith GJ,
Waitzfelder B, Standiford DA, Loots B, on behalf of the SEARCH for Diabetes
in Youths Study Group. Longitudinal association between sex, diabetes self-care
and health related quality of life among youths with type 1 or 2 diabetes mellitus.
J Pediat 2014; 164(6): 1376–1383.
30. Hapunda G, Abubakar A, Pouwer F, van de Vijver F. Diabetes mellitus and
comorbid depression in Zambia. Diabetic Med 2015; 32(6): 814–818.
31. Mommersteeg PMC, Herr R, Pouwer F, Holt RIG, Loerbroks A. The association
between diabetes and an episode of depressive symptoms in the 2002 World
Health Survey: an analysis of 231 797 individuals from 47 countries. Diabetes
Med 2013; 30(6): e208–e214.
32. Hapunda G, Abubakar A, Pouwer F, van de Vijver F. Living with type 1 diabetes
is challenging for Zambian adolescents: Qualitative data on stress, coping with
diabetes and quality of care and life. BMC Endocrine Disorder 2015; 15(20).
33. Mohebi S, Azadbakht L, Feizi A, Sharifirad G, Kargar M. Review the key role of
self-efficacy in diabetes care. J Educat Health Promot 2013: 2(26).
34. Shiqaki C, Kruse RL, Mehr D, Sheldon KM, Bin GE, Moore C, Lemaster J.
Motivation and diabetes self-management. Chronic Illness 2010; 6(3): 202–214.
35. Skinner TC, Hampson SE, Fife-Schaw C. Personality, personal model belief and
self-care in adolescents and young adults with type 1 diabetes. Health Psychol
2002; 21(1): 61–70.
36. Idalski CA, Ellis DA, Weisz A, Naar-King S. Social support for diabetes illness
management: supporting adolescents and caregivers. J Develop Behav Pediat
2011; 32(8): 581–590.
37. Cameron FJ, Scratch SE, Nadebaum C, et al.; DKA Brain Injury Study Group.
Neurological consequences of diabetic ketoacidosis at initial presentation of type
1 diabetes in a prospective cohort study of children. Diabetes Care 2014; 37:
1554–1562.
38. Barnea-Goraly N, Raman M, Mazaika P, et al.; Diabetes Research in Children
Network (DirecNet). Alterations in white matter structure in young children with
type 1 diabetes. Diabetes Care 2014; 37: 332–340.
39. Danquah I, Bedu-Addo G, Mockenhaupt PF. Type 2 diabetes mellitus and
increased risk for malaria infection. Emerg Infect Dis 2010; 16(10): 1601–1604.
40. Cohen DB, Allain TJ, Glover S, Chimbayo D, Dzamalala H, Hofland HW C, Banda
NPK, Zijlstra EE. A survey of the management, control and complications of
diabetes mellitus on patients attending a diabetes clinic in Blantyre, Malawi, an
area of high HIV prevalence. Am J Trop Med Hygiene 2010; 83(3): 575–581.
41. Nieuwesteeg AM, Pouwer F, van de Kamp R, van Bakel HJA, Aanstoot HJ,
Hartman EE. Quality of life of children with type 1 diabetes: A systematic review.
Curr Diabetes Rev 2012; 6(8): 1573–3998.
42. Kakleas K, Kandyla B, Karayianni C, Karavanaki K. Psychosocial problems with
adolescents with type 1 diabetes mellitus. Diabetes Metab 2009; 35: 339–350.
43. Santé Diabéte. Why diabetes in Africa?
diabetes-in-africa (2011, accessed November 2013).
44. Sobgnwi E, Mauvais-Jarvis F, Vexiaus P, Mbanya JC, Gautier JF. Diabetes in
Africans. Part 1: Epidemiology and clinical specificities. Diabetes Metab 2001;
27(6): 628–634.
45. African business. Fast foods – Africa’s fast food love affair
com/usubmit/2014/01/21/7640074.htm (2014, accessed September 2015).
46. International Insulin Foundation and Diabetes Association of Zambia. Final report
of the International Insulin Foundation on the rapid assessment protocol for
insulin access in Zambia, 2004. Available from
uploads/4/9/1/0/4910107/zambia_rapia_report.pdf on June 22, 2017.
47. Beran D, Yudkin JS, de Courten M. Access to care for patients with insulin
requiring diabetes in developing countries: Case studies of Mozambique and
Zambia. Diabetes Care 2005; 28: 2136–2140.
48. Kirigia JM, Sambo HB, Sambo LG, Barry SP. Economic burden of diabetes mellitus
in the WHO African region. BMC Int Health Human Rights 2009; 9(6): DOI:
10.1186/1472-698X-9-6.
49. Delamater AM. Psychological care of children and adolescents with diabetes.
Pediat Diabetes 2009; 10(suppl 12): 175–184.
50. Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al.
Care of children and adolescents with type 1 diabetes. A statement from the
American Diabetes Association. Diabetes Care 2005; 28(1): 186–212.
51. Carrol MF, Schade DS. The dawn phenomenon revisited: implication for diabetes
therapy. Endocrine Pract 2005; 11: 55–64.
52. Porcellati F, Lucide P, Bolli GB, Fanelli CG. Thirty years of research on the dawn
phenomenon: lessons to optimize blood glucose control in diabetes. Diabetes
Care 2013; 36: 3860–3862.
60’s
Packed in
DYNA GLICLAZIDE SR 30 mg. Each tablet contains 30 mg gliclazide. S3 A42/21.2/0249. NAM NS2
12/21.2/0110. For full prescribing information, refer to the package insert approved by the Medicines
Control Council, 10 December 2011. 1) Crepaldi G and Fioretto P. Gliclazide modified release: Its place in the
therapeutic armamentarium. Metabolism 2000;49(10)supplement 2:21-25. 2) McGavin JK, et al. Gliclazide
modified release. Drugs 2002;62(9):1357-1364. 3) Database of Medicine Prices (23 June 2017). Department
of Health website. - Accessed on 23 June 2017. 4) IMS MAT UNITS March 2017.
DGLH420/06/2017.
CUSTOMER CARE LINE 0860 PHARMA (742 762)
for
SUSTAINED
CONTROL
R52,63
Once daily formulation
Improved compliance 1
Sustained 24 hour glycaemic control
26 %
less vs.
market
leader
4 3
2
1